Charles River Laboratories is a leading provider of drug discovery and development services. With roughly 50% of market share worldwide, the research model and services segment is the leading provider of animal models for laboratory testing. About half of the company's revenue comes from drug discovery and preclinical testing, and one fourth comes from the manufacturing support segment.
| Website: | www.criver.com |
| Email: | todd.spencer@crl.com |
| Main Phone: | +1 781 222-6000 |
| Address: | 251 Ballardvale Street |
| State: | MA |
| City / Town: | Wilmington |
| Country: | USA |
| Postal Code: | 01887 |
| Exchange: | NYE |
| CEO: | James C. Foster |
| Employees: | 17100 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
There are now over 92 million Millennials, ranging in age from their late-teens to their mid-30s. Given this age spread, their purchasing power is still emerging.
Deal expected to be accretive by $0.25 in 2018 and $0.60 in 2019.
Retail Sales rose 0.3% in November, unchanged excluding autos and up 0.7% excluding autos and gasoline. Initial Jobless fell to 343,000 in the latest week, but is this a trend below the 350,000
The Dow Jones Industrial Average traded up to 12,830.29 in morning trading then dipped to 12,611.79 into the final half hour of trading, below its 50-day simple moving average at 12,697. The
Retail Sales rose by a less than expected 0.4% in January. Ex-autos the gain was 0.7%. Import Prices rose 0.3% in January. Business Inventories rose by 0.4% in December. The Dow Jones Industrial
Import Prices rose by 0.3% in July and by 14% year over year. Housing Starts fell 1.5% in July to an annual rate of 604,000 with single family starts down 4.9% to 425,000. Building Permits
Wednesday’s strong rebound by China stocks in Hong Kong was only a small interruption the recent powerful rush downward caused mainly by fears over European and U.S. debt and the slowing global
Charles River Laboratories is a leading provider of drug discovery and development services. With roughly 50% of market share worldwide, the research model and services segment is the leading provider of animal models for laboratory testing. About half of the company's revenue comes from drug discovery and preclinical testing, and one fourth comes from the manufacturing support segment.
| Website: | www.criver.com |
| Email: | todd.spencer@crl.com |
| Main Phone: | +1 781 222-6000 |
| Address: | 251 Ballardvale Street |
| State: | MA |
| City / Town: | Wilmington |
| Country: | USA |
| Postal Code: | 01887 |
| Exchange: | NYE |
| CEO: | James C. Foster |
| Employees: | 17100 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
There are now over 92 million Millennials, ranging in age from their late-teens to their mid-30s. Given this age spread, their purchasing power is still emerging.
Deal expected to be accretive by $0.25 in 2018 and $0.60 in 2019.
Retail Sales rose 0.3% in November, unchanged excluding autos and up 0.7% excluding autos and gasoline. Initial Jobless fell to 343,000 in the latest week, but is this a trend below the 350,000
The Dow Jones Industrial Average traded up to 12,830.29 in morning trading then dipped to 12,611.79 into the final half hour of trading, below its 50-day simple moving average at 12,697. The
Retail Sales rose by a less than expected 0.4% in January. Ex-autos the gain was 0.7%. Import Prices rose 0.3% in January. Business Inventories rose by 0.4% in December. The Dow Jones Industrial
Import Prices rose by 0.3% in July and by 14% year over year. Housing Starts fell 1.5% in July to an annual rate of 604,000 with single family starts down 4.9% to 425,000. Building Permits
Wednesday’s strong rebound by China stocks in Hong Kong was only a small interruption the recent powerful rush downward caused mainly by fears over European and U.S. debt and the slowing global
| Last Price 173.61 | Change $ -1.62 | Change % -0.92 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 174.43 | High 175.43 | Low 172.37 | Prev Close 175.23 |
| Last Trade | Volume 255,849 | 52 Wk Hi 179.39 | 52 Wk Low 95.59 |
| Market Cap 8.6 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 49,487,437.00 | EPS (TTM) 4.97 | PE Ratio 34.90 | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 41 | 1000 |
| Number of Buys | 18 | 61 |
| Number of Sells | 23 | 939 |
| Net Activity | 23262 | 64809 |
| Last 10 Buys | Shares |
|---|---|
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 129 | 129 | 129 | 129 |
| Low Target Price Estimate | 102 | 102 | 102 | 102 |
| Mean Target Price Estimate | 118.25 | 118.25 | 118.25 | 118.25 |
| Standard Deviation | 8.65 | 8.65 | 8.65 | 8.65 |
| Date of Most Recent Estimate | 05/31/18 | 05/11/18 | 05/11/18 | 05/31/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K/A | Amendment to a previously filed 8-K | 33 | 2018-06-14 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-06-14 |
| SD | Specialized Disclosure Report | 5 | 2018-05-31 |
| 4/A | Amendment to a previously filed Form 4 | 1 | 2018-05-24 |
| S-8 | Securities offered to employees under employee benefit plans | 10 | 2018-05-18 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 9 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 5 | 6 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.92 | 1.92 | 1.77 | 1.8 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait